Literature DB >> 31548596

Association among the prognostic nutritional index, completion of adjuvant chemotherapy, and cancer-specific survival after curative resection of stage II/III gastric cancer.

Hua Xiao1, Huijun Zhou2, Peng Zhang3, Haifan Xiao4, Ke Liu5, Xiaoyan Chen6, Hu Quan1, Bin Yin1, Rongrong Li2, Gang Huang1, Xianli Yin7, Yongzhong Ouyang8.   

Abstract

BACKGROUND/
OBJECTIVE: To investigate the impact of preoperative immunological and nutritional status, using the prognostic nutritional index (PNI), on completion of planned adjuvant chemotherapy (AC), and the potential additive effects of low PNI and incomplete AC on gastric cancer-specific survival (CSS) after curative resection of stage II/III gastric cancer (GC).
METHODS: Medical records of 1288 consecutive stage II/III GC patients who underwent curative resection and planned to receive AC between November 2010 and December 2017 were retrospectively reviewed. The optimal cut-off value of PNI for CSS was determined by X-tile. The independent predictive factors for incomplete AC were identified using univariate and multivariate analyses. Cox regression analyses assessed the association of low PNI, incomplete AC and CSS.
RESULTS: Of the 1288 patients, 406 (31.5%) completed at least six cycles of AC within 6 months following initial of AC (complete AC). Low PNI (<43.9, n = 386) was identified to be an independent risk factor for incomplete AC (<6 cycles). Both low PNI and incomplete AC independently predicted poor CSS (hazard ratio (HR): 1.287, 95% confidence interval (CI): 1.058-1.565; HR: 1.667, 95% CI: 1.342-2.071). Further analyses confirmed an additive effect with those with both low PNI and incomplete AC having an even worse CSS.
CONCLUSIONS: Low preoperative PNI significantly affects completion of AC. Low PNI and incomplete AC has an additive effect and is associated with even worse outcomes. Further prospective studies are needed to clarify whether perioperative nutrition intervention could improve completion of AC and improve prognosis of GC patients.

Entities:  

Mesh:

Year:  2019        PMID: 31548596     DOI: 10.1038/s41430-019-0502-1

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  9 in total

1.  Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor.

Authors:  Wei Peng; Jing Dai; Chao-Chan Liu; Dian Liu; Hua Xiao
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

2.  Short-Term and Long-Term Outcomes Following Transhiatal versus Right Thoracoabdominal Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction.

Authors:  Jiadi Xing; Maoxing Liu; Kai Xu; Pin Gao; Fei Tan; Zhendan Yao; Nan Zhang; Hong Yang; Chenghai Zhang; Ming Cui; Xiangqian Su
Journal:  Cancer Manag Res       Date:  2020-11-19       Impact factor: 3.989

3.  Cumulative total S-1 dose in adjuvant chemotherapy affects the long-term outcome following curative gastrectomy for gastric cancer.

Authors:  Keiji Nishibeppu; Shuhei Komatsu; Toshiyuki Kosuga; Takeshi Kubota; Kazuma Okamoto; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Eigo Otsuji
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

4.  Nutritional and Clinical Factors Affecting Weight and Fat-Free Mass Loss after Gastrectomy in Patients with Gastric Cancer.

Authors:  Hee-Sook Lim; Bora Lee; In Cho; Gyu Seok Cho
Journal:  Nutrients       Date:  2020-06-27       Impact factor: 5.717

5.  5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?

Authors:  Zining Liu; Yinkui Wang; Fei Shan; Xiangji Ying; Yan Zhang; Shuangxi Li; Yongning Jia; Ziyu Li; Jiafu Ji
Journal:  Cancer Manag Res       Date:  2021-01-11       Impact factor: 3.989

6.  Nutritional Status Indicators Affecting the Tolerability of Postoperative Chemotherapy After Total Gastrectomy in Patients With Gastric Cancer.

Authors:  Kazuhiro Toyota; Masayuki Mori; Satoshi Hirahara; Shoko Yoshioka; Haruna Kubota; Raita Yano; Hironori Kobayashi; Yasushi Hashimoto; Yoshihiro Sakashita; Yujiro Yokoyama; Yoshiaki Murakami; Katsunari Miyamoto
Journal:  J Gastric Cancer       Date:  2022-03-02       Impact factor: 3.720

7.  Association among prognostic nutritional index, post-operative infection and prognosis of stage II/III gastric cancer patients following radical gastrectomy.

Authors:  Yanping Xiao; Gang Wei; Min Ma; Dian Liu; Pan Chen; Hu Quan; Jia Luo; Hua Xiao
Journal:  Eur J Clin Nutr       Date:  2022-03-30       Impact factor: 4.884

8.  Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic ductal adenocarcinoma: a retrospective study.

Authors:  Ankang Wang; Bo Sun; Min Wang; Hao Shi; Zhiwei Huang; Tao He; Qiu Li; Jiaqi Deng; Wenguang Fu; Yu Jiang
Journal:  PeerJ       Date:  2020-03-18       Impact factor: 2.984

9.  Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy.

Authors:  Hua Xiao; Yanping Xiao; Pan Chen; Hu Quan; Jia Luo; Gang Huang
Journal:  Ann Surg Oncol       Date:  2020-09-14       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.